MK-6194 Site of Injection Study in Healthy Adult Participants (MK-6194-013)
Clinical trial NCT06649877 · COMPLETED
Trial details
- NCT number
- NCT06649877
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2023-07-13
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.